Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2021
Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel DiseaseEmily Yelencich, Emily Truong, Adrianne M Widaman, et al.
World Journal of Gastroenterology|June 10, 2024
Excess non-COVID-19-related mortality among inflammatory bowel disease decedents during the COVID-19 pandemicSarah Rotondo-Trivette, Xin-Yuan He, Jamil S Samaan, et al.
Hepatology Communications|May 4, 2023
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scoresMazen Noureddin, Edward Mena, Raj Vuppalanchi, et al.
Hepatology (Baltimore, Md.)|July 9, 2022
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosisDevon Chang, Emily Truong, Edward A Mena, et al.
Hepatology (Baltimore, Md.)|May 19, 2023
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort studyBeom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, et al.
Hepatology Communications|May 9, 2022
Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017-2018Emily Truong, Yee Hui Yeo, Galen Cook-Wiens, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
Cell Stem Cell|November 29, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosisFatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2024
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Pageof 3